Related Experiment Video
Updated: May 23, 2025
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
30.1K
Antivirotics based on defective interfering particles: emerging concepts and challenges.
S V Maryanchik1, S E Borovikova2, A O Ivanova3
1Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.
Frontiers in Cellular and Infection Microbiology
|March 11, 2025
Summary
Defective interfering particles (DIPs) naturally inhibit viral replication by competing for resources. This research explores DIP biology and their potential as a novel antiviral therapy against viral infections.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- Viruses are obligate intracellular parasites, utilizing host cell machinery for replication.
- Targeting viral replication is challenging due to the reliance on host systems, risking cellular toxicity.
- Defective interfering particles (DIPs) are naturally occurring viral mutants that interfere with standard viral replication.
Purpose of the Study:
- To elucidate the fundamental biology of Defective Interfering Particles (DIPs).
- To review advancements in Defective Interfering Particle (DIP)-based antiviral technologies.
- To analyze the therapeutic potential of DIPs and survey current antiviral strategies.
Main Methods:
- Literature review of Defective Interfering Particle (DIP) biology and antiviral applications.
- Analysis of existing preventive and therapeutic antiviral strategies.
- Synthesis of current research on DIPs for novel antiviral development.
Main Results:
- Defective Interfering Particles (DIPs) emerge during viral infections and possess inherent antiviral properties.
- DIPs compete with standard viruses for essential replication resources, thereby inhibiting viral spread.
- Advances in DIP technology show promise for developing targeted antiviral therapies.
Conclusions:
- Defective Interfering Particles (DIPs) represent a promising platform for novel antiviral therapies.
- DIP-based strategies offer a potential alternative to traditional antivirals with reduced host cell toxicity.
- Further research into DIPs can lead to innovative approaches for managing viral infections.
Related Concept Videos
01:10Retrovirus Life Cycles
45.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.5K
00:57Viral Recombination
23.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.2K
00:50What are Viruses?
113.0K
Overview
113.0K
02:33Retroviruses
12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K